Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Quantification of GADD34 Expression in RA [NA]
A rheumatoid arthritis trial evaluating GADD34 expression has completed.
-
FDA approval · 2015-03-25FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
FDA approved a supplemental application for ENBREL (etanercept), expanding its label with additional indications. The submission status indi…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis [Phase 2]
A Phase 2 study evaluating the efficacy, safety, and pharmacokinetics/pharmacodynamics of ocrelizumab in patients with rheumatoid arthritis;…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis [Phase 2]
Phase 2 study evaluating a four-week course of INCB018424 (ruxolitinib) in adults with active rheumatoid arthritis; the trial assessed safet…
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate [Phase 4]
Phase 4 trial of Rituximab (MabThera) in rheumatoid arthritis patients with an inadequate response to methotrexate has completed and results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-03-17Clinical Trial Update: Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients [Phase 2]
A Phase 2 clinical trial evaluating the oral CF101 in combination with methotrexate for rheumatoid arthritis has completed with results post…
-
CLINICAL_TRIALS withdrawal · 2015-03-17Clinical Trial Update: Safety, Pharmacokinetic (PK), Pharmcodynamic (PD), and Drug-Drug Interaction of PLX3397 in Patients With Rheumatoid Arthritis Who Are Receiving Methotrexate [Phase 1]
A Phase 1 study evaluating the safety, pharmacokinetics, pharmacodynamics, and drug-drug interactions of PLX3397 in rheumatoid arthritis pat…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient [Phase 1]
A Phase 1 study evaluating patient performance with the Metoject subcutaneous injection device in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis. [Phase 4]
A Phase 4 trial evaluated Rituximab (MabThera) using MRI to assess treatment in rheumatoid arthritis; results were posted in 2015.
-
CLINICAL_TRIALS research · 2015-03-11Clinical Trial Update: Molecular Mechanism of Neutrophil Necroptosis and Its Roles in RA Pathogenesis
A clinical trial update examining the molecular mechanisms of neutrophil necroptosis and how this process contributes to rheumatoid arthriti…
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Bovine Intestinal Alkaline Phosphatase (bIAP) Modulating Rheumatoid Arthritis [Phase 1, Phase 2]
This clinical trial update reports completed Phase 1/2 studies evaluating bovine intestinal alkaline phosphatase (bIAP) as a modulator for r…
-
CLINICAL_TRIALS research · 2015-03-10Clinical Trial Update: Descriptive Study in Patients Treated With Vimovo™, Including Registration of the Physicians' Prescribing Patterns
A completed descriptive clinical trial evaluating Vimovo (naproxen/esomeprazole) in patients with osteoarthritis, rheumatoid arthritis, and …
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients [Phase 2]
Phase 2 clinical trial evaluating oral CF101 in combination with methotrexate for rheumatoid arthritis; the study is completed and results w…
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial update for oral CF101 tablets in rheumatoid arthritis; study completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Evaluation of Non-surgical Periodontal Therapy in Patients With Rheumatoid Arthritis [NA]
Completed clinical trial evaluating non-surgical periodontal therapy in patients with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday [Phase 4]
This Phase 4 trial evaluated a single IV abatacept dose in rheumatoid arthritis patients already receiving weekly SC abatacept to simulate a…
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate [Phase 2]
Phase 2 study evaluating the efficacy, safety and tolerability of secukinumab in patients with rheumatoid arthritis who are on methotrexate;…
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients [Phase 2]
Phase 2 biomarker study of secukinumab in rheumatoid arthritis has completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-26Clinical Trial Update: An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local Environment [Phase 3]
Results from an open-label Phase 3 study of tocilizumab in rheumatoid arthritis have been completed, with results posted in 2015.
-
FDA label_change · 2015-02-25FDA Approved: SULFASALAZINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for sulfasalazine from Teva Pharmaceuticals USA, updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: Comparative Pharmacokinetic Trial of RGB-03 and MabThera [Phase 1]
This document describes a Phase 1 comparative pharmacokinetic trial of RGB-03 and MabThera (rituximab) in rheumatoid arthritis. The status i…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: INCB047986 in Rheumatoid Arthritis [Phase 2]
The Phase 2 study of INCB047986 for rheumatoid arthritis was terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX) [Phase 2]
Phase 2 dose-finding study evaluating multiple doses of BT061 in active rheumatoid arthritis patients inadequately controlled on methotrexat…
-
CLINICAL_TRIALS trial_result · 2015-02-19Clinical Trial Update: Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy
A completed clinical trial evaluating longitudinal changes in fatigue and health status in rheumatoid arthritis patients treated with a subc…
-
CLINICAL_TRIALS withdrawal · 2015-02-13Clinical Trial Update: The Canadian Follow-up Program for the ATTRACT Study (P04868)(TERMINATED)
The Canadian follow-up program for the ATTRACT study in rheumatoid arthritis has been terminated.